FNY Managed Accounts’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
HCM
NC
FNY Managed Accounts's TEVA Position: Q1 2018 in Review
FNY Managed Accounts opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2018: 585 shares worth $9K. The stake represents 0.01% of the portfolio and ranks #160 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in TEVA as recently as Q1 2017.
FNY Managed Accounts first reported a position in TEVA in Q1 2014 and has held it in 4 quarters since. The position peaked at $343K in Q2 2015. 506 funds tracked by Wall St. Rank hold TEVA as of Q1 2018.
- FNY Managed Accounts held 585 shares of Teva Pharmaceuticals worth $9K as of Q1 2018.
- Teva Pharmaceuticals was a new FNY Managed Accounts position in Q1 2018.
- Teva Pharmaceuticals made up 0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #160 holding.
- FNY Managed Accounts first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 4 quarters since.
- FNY Managed Accounts's Teva Pharmaceuticals position peaked at $343K in Q2 2015.
- 506 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.